Rosetta Genomics Ltd. (NASDAQ:ROSG) is scheduled to be releasing its earnings data after the market closes on Wednesday, August 16th.

Rosetta Genomics Ltd. (ROSG) opened at 1.73 on Wednesday. The firm’s market capitalization is $3.23 million. Rosetta Genomics Ltd. has a 1-year low of $1.40 and a 1-year high of $13.32. The firm’s 50-day moving average is $2.14 and its 200-day moving average is $3.36.

TRADEMARK VIOLATION WARNING: “Rosetta Genomics Ltd. (NASDAQ:ROSG) to Release Earnings on Wednesday” was originally posted by American Banking News and is owned by of American Banking News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/08/09/rosetta-genomics-ltd-nasdaqrosg-to-release-earnings-on-wednesday.html.

About Rosetta Genomics

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).

Receive News & Ratings for Rosetta Genomics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.